TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KINASES RECEPTORS, INCLUDING IGF-IR
A Standard patent application filed on credited to CAMPHAUSEN, Ray ; FABRIZIO, David ; WRIGHT, Martin C. ; GAGE, Patrick ; MENDLEIN, John
Details
Application number :
2013204133
Application type :
Standard
Application status :
FILED
Under opposition :
No
Proceeding type :
Invention title :
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KINASES RECEPTORS, INCLUDING IGF-IR
Inventor :
CAMPHAUSEN, Ray ; FABRIZIO, David ; WRIGHT, Martin C. ; GAGE, Patrick ; MENDLEIN, John